Almac Group services

Almac Diagnostic Services can also help Biopharma clients validate reliable Pharmacodynamic (PD) Biomarker assays that can help provide invaluable guidance within their drug development programmes. Almac also has extensive experience in the discovery of clinically applicable biomarkers, through our own range of Almac proprietary assays (DDIR, Prostate Dx, ColDx, Angio, and EMT) and through developing biomarkers for our partners. As part of our commercial CDx partnerships, we have discovered novel molecular pathways that have been brought forward and developed into Research Assays, Clinical Trial Assays, and full Companion Diagnostics.

We are uniquely placed to partner with clients throughout the entire process of CDx Development through our Clinical Trial Diagnostic Solutions.